BioPharma Credit BOPCF Stock
0.92 USD
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
United States
Exchange
Other OTC
Market Cap
1.29B USD
LOW - HIGH [24H]
0.92
-
0.92 USD
VOLUME [24H]
35 USD
{{ volume }}
P/E Ratio
14.83
Earnings per share
0.06 USD
BioPharma Credit Price Chart
BioPharma Credit BOPCF Financial and Trading Overview
| BioPharma Credit stock price | 0.92 USD |
| Previous Close | 0.91 USD |
| Open | 0.91 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.91 - 0.91 USD |
| 52 Week Range | 0.9 - 1 USD |
| Volume | 54.47K USD |
| Avg. Volume | 77.02K USD |
| Market Cap | 1.28B USD |
| Beta (5Y Monthly) | 0.231034 |
| PE Ratio (TTM) | 14.707162 |
| EPS (TTM) | 0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BOPCF Valuation Measures
| Enterprise Value | 1.08B USD |
| Trailing P/E | 14.707162 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.852304 |
| Price/Book (mrq) | 0.8992544 |
| Enterprise Value/Revenue | 4.959 |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioPharma Credit Stock Price History
| Beta (5Y Monthly) | 0.231034 |
| 52-Week Change | -6.95% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1 USD |
| 52 Week Low | 0.9 USD |
| 50-Day Moving Average | 0.94 USD |
| 200-Day Moving Average | 0.94 USD |
BOPCF Share Statistics
| Avg. Volume (3 month) | 77.02K USD |
| Avg. Daily Volume (10-Days) | 65.39K USD |
| Shares Outstanding | 914.25M |
| Float | 1.13B |
| Short Ratio | N/A |
| % Held by Insiders | 7.69% |
| % Held by Institutions | 39.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.07 |
| Trailing Annual Dividend Yield | 7.67% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 83.56% |
| Operating Margin (ttm) | 83.57% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 8.33% |
| Return on Equity (ttm) | 13.49% |
Income Statement
| Revenue (ttm) | 218.17M USD |
| Revenue Per Share (ttm) | 0.16 USD |
| Quarterly Revenue Growth (yoy) | 174.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 182.31M USD |
| Diluted EPS (ttm) | 0.062 |
| Quarterly Earnings Growth (yoy) | 180.40% |
Balance Sheet
| Total Cash (mrq) | 120.53M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.337 |
| Book Value Per Share (mrq) | 1.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 184.28M USD |
| Levered Free Cash Flow (ttm) | 124.09M USD |
Profile of BioPharma Credit
| Country | United States |
| State | N/A |
| City | London |
| Address | 65 Gresham Street |
| ZIP | EC2V 7NQ |
| Phone | N/A |
| Website | https://www.bpcruk.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Q&A For BioPharma Credit Stock
What is a current BOPCF stock price?
BioPharma Credit BOPCF stock price today per share is 0.92 USD.
How to purchase BioPharma Credit stock?
You can buy BOPCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioPharma Credit?
The stock symbol or ticker of BioPharma Credit is BOPCF.
How many shares does BioPharma Credit have in circulation?
The max supply of BioPharma Credit shares is 1.4B.
What is BioPharma Credit Price to Earnings Ratio (PE Ratio)?
BioPharma Credit PE Ratio is 14.83871000 now.
What was BioPharma Credit earnings per share over the trailing 12 months (TTM)?
BioPharma Credit EPS is 0.06 USD over the trailing 12 months.